Disease | paranasal sinus cancer |
Phenotype | C0854995|paranasal sinus cancer |
Sentences | 3 |
PubMedID- 24318470 | Thirty-six patients with paranasal sinus cancer who were treated by intra-arterial (i-a) chemotherapy concurrent to radiotherapy from april 2010 to january 2012 were included in this study. |
PubMedID- 24472378 | It has been reported that the prevalence of paranasal sinus cancer is higher in workers working with chromium compound manufacture, chromium-containing paint products, and chromium plating. |
PubMedID- 24353544 | Acc is the second most common malignancy and accounts for 5% to 15% of all paranasal sinus cancers.1 the maxillary sinus is the most common site.2,3 because of late detection owing to sinusitis-like symptoms and relative surgical inaccessibility owing to important adjacent structures, maxillary acc is recognized to have a unfavorable prognosis.2,3 many studies have indicated that surgery with postoperative adjuvant radiation therapy is the main strategy for sinonasal acc.2-4 however, patients who were treated with surgery and postoperative radiation had a high recurrence rate of 65%.2 in our case, local recurrence six months after initial surgery and radiation treatment was observed. |
Page: 1